Dominique Plantaz
Expertise in
16
conditions

Dominique Plantaz

Grenoble, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
16
conditions
Grenoble, FR 

Overview

Dominique Plantaz practices practicing medicine in Grenoble, France.

Plantaz is highly rated in 16 conditions, according to our data. Their clinical expertise encompasses Lysosomal Acid Lipase Deficiency, Cholesteryl Ester Storage Disease, Wolman Disease, Bone Marrow Transplant, and Splenectomy.

They are actively involved in clinical research, co-authoring 104 peer reviewed articles and participating in 10 clinical trials.

Locations

Grenoble, France
Other Locations
CHU Bordeaux
Bordeaux, France
Toulouse, France
Nantes, France
Av. Des Maquis Du Grésivaudan, La Tronche, 38700, France
Amiens, France
Montpellier, 34090, France
Poitiers, France
Paris, France
Saint-etienne-de-valoux, 75012, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Device
Study Drugs: Melphalan or Melphalan + Topotecan, Etoposide, Carboplatin and Vincristine, Carboplatin, Intravitreal Melphalan Chemotherapy Injections
Study Phase: Phase 2/Phase 3
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Etoposide, Vincristine, Carboplatin, Cyclophosphamide, Thiotepa
Study Phase: Phase 2
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Radiation, Drug, Procedure
Study Drugs: VDC-IE x2, VDC-IE, TEMIRI, Consolidation BuMel, Maintenance
Study Phase: Phase 2
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
Review of the Paediatric Pleuropulmonary Blastoma French Series
Review of the Paediatric Pleuropulmonary Blastoma French Series
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Other
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Enrollment Status: Unknown
Publish Date: August 23, 2018
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Enrollment Status: Completed
Publish Date: July 24, 2018
Intervention Type: Biological
Study Phase: Not Applicable
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

104 Total Publications

Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study.
Analysis of infectious complications in paediatric autoimmune neutropenia: a French nationwide retrospective cohort study.
Journal: Archives of disease in childhood
Published: August 05, 2025

Frequently Asked Questions about Dominique Plantaz

Is Dominique Plantaz a top-rated expert for Lysosomal Acid Lipase Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Dominique Plantaz is classified as an Distinguished expert for Lysosomal Acid Lipase Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dominique Plantaz participate in research or clinical trials?

Yes. Dominique Plantaz has published 104 articles and abstracts on conditions like Lysosomal Acid Lipase Deficiency. You can view a list of Dominique Plantaz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Plantaz's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile